Article
Dysferlin mediates the cytoprotective effects of TRAF2 following myocardial ischemia reperfusion injury.
Journal of the American Heart Association - 26 Feb 2014
Tzeng Huei-Ping, Evans Sarah, Gao Feng, Chambers Kari, Topkara Veli K, Sivasubramanian Natarajan, Barger Philip M, Mann Douglas L
Abstract excerpt
BACKGROUND: We have demonstrated that tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2), a scaffolding protein common to TNF receptors 1 and 2, confers cytoprotection in the heart. However, the mechanisms for the cytoprotective effects of TRAF2 are not known. METHODS/RESULTS: Mice with cardiac-restricted overexpression of low levels of TRAF2 (MHC-TRAF2LC) and a dominant negative TRAF2 (MHC-TRAF2DN)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
